• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泼尼松龙对血小板功能具有精细的抑制作用。

Prednisolone exerts exquisite inhibitory properties on platelet functions.

机构信息

William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London, United Kingdom.

出版信息

Biochem Pharmacol. 2012 May 15;83(10):1364-73. doi: 10.1016/j.bcp.2012.02.006. Epub 2012 Feb 16.

DOI:10.1016/j.bcp.2012.02.006
PMID:22366284
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3320711/
Abstract

We have previously reported presence of the glucocorticoid (GC) receptor (GR) alpha on blood platelets, and its ability to modulate platelet aggregation when activated by the synthetic GC prednisolone (Pred). In the present study we investigated the effects of Pred on broader aspects of platelet functions to unveil novel non-genomic actions on this cell type. Using whole blood assay we demonstrated that Pred was the only GC able to inhibit platelet aggregation and platelet-monocyte interactions. This latter effect was due to regulation of platelets, not monocytes. We next examined the effects of Pred on physiological actions of platelets, observing inhibition of platelet adhesion and spreading on collagen under static conditions. Moreover Pred inhibited thrombus formation under flow, suggesting potential important effects in haemostasis and thrombosis. Pred was unable to regulate platelet reactivity under conditions where the effects of platelet-derived ADP and TxA₂ were blocked, suggesting that the GC targeted the activation-dependent component of the adhesion and aggregation response. The effects of Pred were not mediated through cyclic nucleotide signaling, but rather seemed to evolve around selective regulation of P2Y₁₂ ADP receptor signaling, intimating a novel mode of action. This study details the actions of Pred on platelets unveiling novel properties which could be relevant for this GC in controlling unwanted vascular and thrombotic diseases.

摘要

我们之前曾报道过糖皮质激素(GC)受体(GR)α存在于血小板中,并且当它被合成 GC 泼尼松龙(Pred)激活时,能够调节血小板聚集。在本研究中,我们研究了 Pred 对血小板功能更广泛方面的影响,以揭示这种细胞类型的新的非基因组作用。使用全血测定,我们证明 Pred 是唯一能够抑制血小板聚集和血小板-单核细胞相互作用的 GC。后一种作用是由于对血小板的调节,而不是单核细胞。接下来,我们研究了 Pred 对血小板生理作用的影响,观察到在静态条件下抑制血小板在胶原上的黏附和铺展。此外,Pred 抑制了流动状态下的血栓形成,表明在止血和血栓形成方面可能具有重要的潜在作用。当阻断血小板衍生的 ADP 和 TxA₂的作用时,Pred 不能调节血小板反应性,这表明 GC 靶向黏附和聚集反应的激活依赖性成分。Pred 的作用不是通过环核苷酸信号传导介导的,而是似乎围绕着对 P2Y₁₂ ADP 受体信号传导的选择性调节展开,暗示了一种新的作用模式。这项研究详细描述了 Pred 对血小板的作用,揭示了这种 GC 控制不需要的血管和血栓性疾病的新特性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d7/3320711/e09d051dcb17/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d7/3320711/4eda87b7a5c5/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d7/3320711/3d696fae5fda/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d7/3320711/5a89aaf0261e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d7/3320711/85f35a4c5386/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d7/3320711/28426702ea1b/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d7/3320711/e61ee774c15f/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d7/3320711/e09d051dcb17/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d7/3320711/4eda87b7a5c5/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d7/3320711/3d696fae5fda/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d7/3320711/5a89aaf0261e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d7/3320711/85f35a4c5386/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d7/3320711/28426702ea1b/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d7/3320711/e61ee774c15f/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d7/3320711/e09d051dcb17/gr6.jpg

相似文献

1
Prednisolone exerts exquisite inhibitory properties on platelet functions.泼尼松龙对血小板功能具有精细的抑制作用。
Biochem Pharmacol. 2012 May 15;83(10):1364-73. doi: 10.1016/j.bcp.2012.02.006. Epub 2012 Feb 16.
2
Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.非肽类分子BIBU52对糖蛋白IIb/IIIa受体的拮抗作用:体外抑制血小板聚集及体内抗血栓形成疗效
J Cardiovasc Pharmacol. 1997 Aug;30(2):261-72. doi: 10.1097/00005344-199708000-00017.
3
Inhibitory action of gliclazide on platelet functions.格列齐特对血小板功能的抑制作用。
Diabetes Res Clin Pract. 1989 Aug 1;7(2):141-7. doi: 10.1016/0168-8227(89)90105-8.
4
Effects of P2Y(1) receptor antagonism on the reactivity of platelets from patients with stable coronary artery disease using aspirin and clopidogrel.在阿司匹林和氯吡格雷治疗稳定型冠心病患者中,P2Y(1)受体拮抗剂对血小板反应性的影响。
Br J Pharmacol. 2012 May;166(1):221-31. doi: 10.1111/j.1476-5381.2011.01683.x.
5
Neferine exerts its antithrombotic effect by inhibiting platelet aggregation and promoting dissociation of platelet aggregates.荷叶碱通过抑制血小板聚集和促进血小板聚集物的解离来发挥其抗血栓作用。
Thromb Res. 2013 Aug;132(2):202-10. doi: 10.1016/j.thromres.2013.05.018. Epub 2013 Jun 14.
6
Pharmacological actions of neferine in the modulation of human platelet function.荷叶碱对人血小板功能调节的药理作用。
Eur J Pharmacol. 2019 Nov 5;862:172626. doi: 10.1016/j.ejphar.2019.172626. Epub 2019 Aug 21.
7
Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.糖蛋白Iba1α抑制药和二磷酸腺苷(ADP)受体拮抗剂可减少暴露于动脉粥样硬化斑块的流动血液中的血小板血栓形成,但阿司匹林无此作用。
Thromb Haemost. 2007 Mar;97(3):435-43.
8
The P2Y(12) antagonists, 2MeSAMP and cangrelor, inhibit platelet activation through P2Y(12)/G(i)-dependent mechanism.P2Y(12)拮抗剂 2MeSAMP 和坎格雷洛通过 P2Y(12)/G(i)-依赖性机制抑制血小板活化。
PLoS One. 2012;7(12):e51037. doi: 10.1371/journal.pone.0051037. Epub 2012 Dec 6.
9
Adenosine diphosphate receptors on blood platelets: potential new targets for antiplatelet therapy.血小板上的二磷酸腺苷受体:抗血小板治疗的潜在新靶点。
Acta Biochim Pol. 2005;52(2):411-5. Epub 2005 May 15.
10
Platelets as a novel source of Gremlin-1: Implications for thromboinflammation.血小板作为Gremlin-1的新来源:对血栓炎症的影响。
Thromb Haemost. 2017 Jan 26;117(2):311-324. doi: 10.1160/TH16-08-0665. Epub 2016 Dec 8.

引用本文的文献

1
Platelets and diseases: signal transduction and advances in targeted therapy.血小板与疾病:信号转导及靶向治疗进展
Signal Transduct Target Ther. 2025 May 16;10(1):159. doi: 10.1038/s41392-025-02198-8.
2
NR4A1 Acts as a Novel Regulator of Platelet Activation and Thrombus Formation.NR4A1作为血小板活化和血栓形成的新型调节因子。
Circ Res. 2025 Apr 11;136(8):809-826. doi: 10.1161/CIRCRESAHA.124.325645. Epub 2025 Mar 4.
3
Advances in the Pathogenesis of Steroid-Associated Osteonecrosis of the Femoral Head.类固醇相关性股骨头坏死发病机制的研究进展。

本文引用的文献

1
Antiallergic cromones inhibit neutrophil recruitment onto vascular endothelium via annexin-A1 mobilization.抗过敏克酮通过动员膜联蛋白 A1 抑制中性粒细胞向血管内皮细胞的募集。
Arterioscler Thromb Vasc Biol. 2010 Sep;30(9):1718-24. doi: 10.1161/ATVBAHA.110.209536. Epub 2010 Jun 17.
2
Multiple electrode aggregometry predicts stent thrombosis better than the vasodilator-stimulated phosphoprotein phosphorylation assay.多电极聚集法比血管扩张刺激磷蛋白磷酸化试验更能预测支架血栓形成。
J Thromb Haemost. 2010 Feb;8(2):351-9. doi: 10.1111/j.1538-7836.2009.03699.x. Epub 2009 Nov 23.
3
The platelet as a model system for the acute actions of nuclear receptors.
Biomolecules. 2024 Jun 6;14(6):667. doi: 10.3390/biom14060667.
4
Oxidative Stress Induced by Cortisol in Human Platelets.皮质醇诱导的人血小板氧化应激。
Int J Mol Sci. 2024 Mar 28;25(7):3776. doi: 10.3390/ijms25073776.
5
Cardiac injury progression in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection: a review.与SARS-CoV-2感染相关的儿童多系统炎症综合征中心脏损伤的进展:综述
Front Pediatr. 2024 Mar 6;12:1348016. doi: 10.3389/fped.2024.1348016. eCollection 2024.
6
Changes in the Proteome of Platelets from Patients with Critical Progression of COVID-19.COVID-19 重症进展患者血小板蛋白质组的变化。
Cells. 2023 Sep 1;12(17):2191. doi: 10.3390/cells12172191.
7
Platelets and the Lectin Pathway of Complement Activation in Patients with Systemic Lupus Erythematosus or Antiphospholipid Syndrome.系统性红斑狼疮或抗磷脂综合征患者的血小板与补体激活的凝集素途径
TH Open. 2023 Jun 15;7(2):e155-e167. doi: 10.1055/a-2087-0314. eCollection 2023 Apr.
8
Platelets exacerbate cardiovascular inflammation in a murine model of Kawasaki disease vasculitis.血小板在川崎病血管炎的小鼠模型中加剧心血管炎症。
JCI Insight. 2023 Jul 24;8(14):e169855. doi: 10.1172/jci.insight.169855.
9
Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?治疗外源性糖皮质激素的副作用;我们能否辨别好坏?
Endocr Rev. 2023 Nov 9;44(6):975-1011. doi: 10.1210/endrev/bnad016.
10
[Analysis of incidence and clinical characteristics of osteonecrosis of femoral head in patients with systemic lupus erythematosus treated with glucocorticoid: A descriptive study based on a prospective cohort].糖皮质激素治疗系统性红斑狼疮患者股骨头坏死的发病率及临床特征分析:一项基于前瞻性队列的描述性研究
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2023 May 15;37(5):605-614. doi: 10.7507/1002-1892.202302026.
血小板作为核受体急性作用的模型系统。
Steroids. 2010 Aug-Sep;75(8-9):570-5. doi: 10.1016/j.steroids.2009.09.005. Epub 2009 Sep 22.
4
Nitric oxide inhibits von Willebrand factor-mediated platelet adhesion and spreading through regulation of integrin alpha(IIb)beta(3) and myosin light chain.一氧化氮通过调节整合素 α(IIb)β(3)和肌球蛋白轻链抑制血管性血友病因子介导的血小板黏附和铺展。
J Thromb Haemost. 2009 Dec;7(12):2106-15. doi: 10.1111/j.1538-7836.2009.03619.x. Epub 2009 Sep 18.
5
The formation of monocyte-platelet aggregates is independent of on-treatment residual agonists'-inducible platelet reactivity.单核细胞-血小板聚集的形成与治疗后残留激动剂诱导的血小板反应无关。
Atherosclerosis. 2009 Dec;207(2):608-13. doi: 10.1016/j.atherosclerosis.2009.05.037. Epub 2009 Jun 18.
6
Intracellular molecular signaling. Basis for specificity to glucocorticoid anti-inflammatory actions.细胞内分子信号传导。糖皮质激素抗炎作用特异性的基础。
Ann N Y Acad Sci. 2009 Feb;1153:6-13. doi: 10.1111/j.1749-6632.2008.03958.x.
7
Nitric oxide specifically inhibits integrin-mediated platelet adhesion and spreading on collagen.一氧化氮特异性抑制整合素介导的血小板在胶原蛋白上的黏附和铺展。
J Thromb Haemost. 2008 Dec;6(12):2175-85. doi: 10.1111/j.1538-7836.2008.03190.x. Epub 2008 Oct 11.
8
Greater reduction of platelet activation markers and platelet-monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease.在稳定型冠状动脉疾病中,与氯吡格雷相比,普拉格雷能更大程度地降低血小板活化标志物和血小板 - 单核细胞聚集体水平。
Thromb Haemost. 2008 Oct;100(4):626-33.
9
Endothelial dysfunction, impaired endogenous platelet inhibition and platelet activation in diabetes and atherosclerosis.糖尿病和动脉粥样硬化中的内皮功能障碍、内源性血小板抑制受损及血小板活化
Curr Vasc Pharmacol. 2008 Jan;6(1):52-60. doi: 10.2174/157016108783331295.
10
Platelet activation and atherothrombosis.血小板活化与动脉粥样硬化血栓形成。
N Engl J Med. 2007 Dec 13;357(24):2482-94. doi: 10.1056/NEJMra071014.